MEDICAL SPECIALITIES A.CARDIOVASCULAR INFECTIONS
|
|
- Rebecca Briggs
- 5 years ago
- Views:
Transcription
1 MEDICAL SPECIALITIES A.CARDIOVASCULAR INFECTIONS Infection/Condition/lik ely organism Infective endocarditis native valve/due to Penicillin- Susceptible Streptococcus Viridans/S.bovis Suggested treatment Preferred Inj. Aqueous Crystalline penicillin million units/24 hr i.v continuously or in 4 or 6 divided doses * Gentamicin 3 mg/kg dose (2weeks) Alternative Ceftriaxone sodium 2 g/24 h IV/IM in 1 dose Gentamicin 3 IV/IM in 1 dose(2 weeks) OR Vancomycin 30 IV in 2 equally divided doses not exceed 2 g/24 h unless concentrations in serum are inappropriately low Comment *Preferred in most patients >65 y or patients with impairment of 8th cranial nerve function or renal or function #2-wk regimen not intended for patients with known cardiac or extracardiac abscess or for those with creatinine clearance of >20 ml/min, impaired 8th cranial nerve function, or Abiotrophia, Granulicatella, or Gemella spp infection; gentamicin dosage should be adjusted to achieve peak serum concentration of 3 4 µg/ml and trough serum concentration of < 1µg /ml when 3 divided doses are used; nomogram used for single daily dosing
2 Native Valve Endocarditis Caused by Strains of Viridans Group Streptococci and Streptococcus bovis Relatively Resistant to Penicillin [Minimum inhibitory concentration (MIC) >0.12 µg/ml 0.5 µg/ml] Inj. Aqueous Crystalline penicillin 24 million units/24 hr i.v continuously or in 4 or 6 divided doses Gentamicin 3 mg/kg dose (2 weeks) Ceftriaxone sodium 2 g/24 h IV/IM in 1 dose Gentamicin 3 IV/IM in 1 dose (2 Vancomycin therapy recommended only for patients unable to tolerate penicillin or ceftriaxone; vancomycin dosage should be adjusted to obtain peak (1 h after infusion completed) serum concentration of µg /ml and a trough concentration range of µg /ml Patients with endocarditis caused by penicillin-resistant (MIC >0.5 µg/ml) strains should be treated with regimen recommended for enterococcal endocarditis OR Vancomycin 30 IV in 2 equally divided doses not exceed 2 g/24 h unless concentrations in serum are inappropriately low Vancomycin therapy recommended only for patients unable to tolerate penicillin or ceftriaxone therapy
3 Endocarditis of prosthetic valve or other prosthetic material Caused by Viridans Group Streptococci and Streptococcus bovis Penicillin-susceptible strain (minimum inhibitory concentration <0.12 µg/ml) Inj. Aqueous Crystalline penicillin 24 million units/24 hr i.v continuously or in 4 or 6 divided doses 6weeks) With/without Gentamicin 3 mg/kg dose (2 weeks) Ceftriaxone sodium 2 g/24 h IV/IM in 1 dose With/without Gentamicin 3 IV/IM in 1 dose (2 weeks) OR Vancomycin 30 IV in 2 equally divided doses not exceed 2 g/24 h unless concentrations in serum are inappropriately low Penicillin or ceftriaxone together with gentamicin has not demonstrated superior cure rates compared with monotherapy with penicillin or ceftriaxone for patients with highly susceptible strain; gentamicin therapy should not be administered to patients with creatinine clearance of <30 ml/min Vancomycin therapy recommended only for patients unable to tolerate penicillin or ceftriaxone therapy Penicillin relatively or fully resistant strain (minimum inhibitory concentration >0.12 µg/ml) Inj. Aqueous Crystalline penicillin 24 million units/24 hr i.v continuously or in 4 or 6 divided doses 6weeks) Ceftriaxone sodium 2 g/24 h IV/IM in 1 dose
4 Gentamicin 3 mg/kg dose (2weeks) Gentamicin 3 IV/IM in 1 dose(2 weeks) OR Vancomycin 30 IV in 2 equally divided doses not exceed 2 g/24 h unless concentrations in serum are inappropriately low Endocarditis Caused by Staphylococci in the Absence of Prosthetic Materials For Oxacillin resistant strains Nafcillin or oxacillin* 12 g/24 h IV in 4 6 equally divided doses 6weeks) With/optional Gentamicin 3 mg/kg dose (3-5d) Vancomycin 30 IV in 2 equally divided For penicillin allergic,nonanaphylactoid: Cefazolin 6 g/24 h IV/IM in 3 divided dose Gentamicin 3 IV/IM in 1 dose(2 weeks) * Penicillin G 24 million U/24 h IV in 4 to 6 equally divided doses may be used in place of nafcillin or oxacillin if strain is penicillin susceptible (minimum inhibitory concentration <0.1 µg/ml) and does not produce β- lactamase -For complicated right-sided IE and for left-sided IE; for uncomplicated right-sided IE, 2 wk therapy -Adjust vancomycin dosage to achieve
5 Endocarditis Caused by Staphylococci in Prosthetic valve doses Nafcillin or oxacillin* 12 g/24 h IV in 4 6 equally divided doses 6weeks) Rifampin 900 mg per 24 h IV/PO in 3 equally divided doses 6weeks) Gentamicin 3 mg/kg dose (2 weeks) 1-h serum concentration of µg/ml and trough concentration of µg/ml * Penicillin G 24 million U/24 h IV in 4 to 6 equally divided doses may be used in place of nafcillin or oxacillin if strain is penicillin susceptible (minimum inhibitory concentration <0.1 µg/ml) and does not produce β- lactamase) Oxacillin resistant Staphylococci Vancomycin 30 IV in 2 equally divided Doses 6weeks) Rifampin 900 mg per 24 h IV/PO in 3 equally divided doses 6weeks) Adjust vancomycin dosage to achieve 1-h serum concentration of µg/ml and trough concentration of µg/ml Gentamicin 3 mg/kg dose (2 weeks) Endocarditis Caused by Enterococci (native and prosthetic) Ampicillin sodium 12 g/24 h IV in 6 equally divided doses (4-6 weeks)# OR Aqueous crystalline penicillin G sodium Vancomycin* 30 mg/kg per 24 h IV in 2 equally divided Doses 6weeks) # Native valve: 4- wk therapy recommended for patients with symptoms of illness 3
6 18 30 million U/24 h IV either continuously or in 6 equally divided doses (4-6Weeks)# Gentamicin$ 3 mg/kg dose (4-6 weeks)# Gentamicin 3 IV/IM in 1 dose (6 weeks) mo; 6-wk therapy recommended for patients with symptoms 3 mo * Vancomycin therapy recommended only for patients unable to tolerate penicillin or ampicillin $ If gentamicin resistant strain, Streptomycin 15 IV/IM in 2 equally divided Doses for 6weeks given Acute Rheumatic Fever (Secondary prophylaxis) Benzathine Penicillin IM 1.2 mega units (>30kg); 0.6 mega units (<30 kg) every 3-4 weeks Duration With carditis: 10 years or until 25 years of age Without carditis: 5 years or until 18 years of age OR Cephalexin 250mg bd orally 1 hour prior to procedure Penicillin V potassium 250 mg orally twice daily Penicillin allergy Erythromycin 250mg bd Secondary Prophylaxis should only be ceased following: No ARF signs/symptoms for at least 5 years, and Medical Specialist review (Paediatrician / Physician / Cardiologist) and Echocardiogram to establish presence & severity of RHD (if available) Treatment of Pacemaker infections Antibiotic Duration Comment While awaiting Complete removal
7 microbiological diagnosis provide empirical cover for MRSA with: Vancomycin 15mg/kg IV q12h not to exceed 2g/24h (unless serum levels are monitored) Infection of pulse generator pocket with blood stream infection Lead associated endocarditis Change antibiotics according to culture results days 6 weeks of the entire implanted system including the cardiac leads is recommended even in patients with clinical infection of the pocket only The new implant can be placed on the contra lateral side 10 to 14 days after the removal of the implanted system in patients with infection of the pulse generator pocket and as late as 6 weeks in those with endocarditis Reference: American Heart Association Guideline 2005 B. CENTRAL NERVOUS SYSTEM INFECTIONS Infection/Conditi on/likely organism Acute bacterial meningitis Common organisms: Streptococcus pneumoniae Neisseria meningitidis Haemophilus influenzae Other organisms: Gram negative rods Leptospirosis Scrub typhus Suggested treatment Preferred Cefotaxime 200mg/kg/24h IV in 3 divided doses (max: 12g/day). Usual dose is 2g q8h+ Inj Vancomycin 500mg I.V Q6h for days Alternative Inj Ceftriaxone 2gm Q12h I.V. for days + Inj Vancomycin 500mg I.V Q6h for days Comment
8 Melioidosis Mycoplasma pneumoniae Viral encephalitis Herpes simplex Acyclovir 5mg/kg IV q8h for days Herpes zoster Brain Abscess Acyclovir 10mg/kg IV q8h for days Inj Ceftriaxone 2gm I.V. Q12h +Inj Amikacin 500mg IV Q8h + Inj Metronidazole I.V500mg I.V Q8h x 14 days Add vancomycin mg/kg IV if secondary to trauma Duration of antibiotic would depends on response by neuroimaging; 4-8 weeks may be needed) C.GASTROINTESTINAL INFECTIONS Infection/Conditi Suggested treatment on/likely organism Preferred Alternative Acute Antibiotics not gastroenteritis recommended (Usually viral, Enteropathogenic or Enterotoxigenic E.coli) Comment Oral rehydration is the cornerstone of treatment Bacillary dysentery ( Shigella spp) Cholera Tab Ciprofloxacin 500 mg bd X 5 days Cap Doxycycline 300 mg, single dose (6mg/ Tab Cefixime 200mg bd X 5 days (8mg/kg/day) Tab Ciprofloxacin 1gm single dose Most mild infections resolved spontaneously without antibiotics Ciprofloxacin to be avoided if isolates are nalidixic acid resistant Prompt rehydration essential, antibiotic
9 kg, maximum 300 mg Giardiasis Metronidazole 200 mg PO tds for 5-7 days Amoebic dysentery Metronidazole 400mg tds for 7 days Typhoid fever Outpatients- Ciprofloxacin* 750mg p.o bd x 14days If no clinical response then switch to Inj Ceftriaxone 1gm I.V. BD for 14 days Acute cholecystitis Ceftriaxone 1-2 gm every 12hourly x 7 days with Metronidazole 500mg 8th - 12th hourly x 5-7 Acute cholangitis (Gram negative, anaerobes, gram positive) Spontaneous Bacterial Peritonitis Secondary peritonitis (bowel perforation), Intra abdominal abscess Ticarcillin/clavul anic acid 3.1gm IV 4-6hrly X days plus Metronidazole 500 mgi.v. tds x 5-7 days Cefotaxime 2g IV q8h for 7-10 days Ceftriaxone IV 2gm 12 hourly x 14 days with Metronidazole 500mg 8hrly Tinidazole 2gm 1 dose Outpatients- Tab. Cefixime (20mg/kg/day)max.400mg/da y for days Cefepime 2 gm every 8-12 hours in combination with Metronidazole 500mg 8th - 12th hourly x 5-7 Piperacillin -Tazobactam 4.5 gm 6hrly i.v. plus Metronidazole 500 mg I.V. tds x 5-7 days Ceftriaxone IV 2gm 12 hourly x 7-10 days therapy is only adjunct to rehydration Treatment with Ciprofloxacin is discouraged due to high clinical failure seen in disease with isolates having intermediate MIC Antibiotics to be continued until resolution of clinical signs of infection,
10 H. pylori associated disease, gastric MALT1 lymphomas Amoebic liver abscess x 7 days Omeprazole 20mg bd + Clarithromycin 500mg p. o bd +Amoxicillin 1gm bd p.o x 14 days Metronidazole 500mg IV tdsx 10days Bismuth subsalicylate 2tab qid+ Tetracycline 500mg qid+metronidazole 500mgtid+Omeprazole 20mg bd D. SKIN & SOFT TISSUE INFECTIONS Infection/Conditi Suggested treatment on/likely organism Preferred Alternative Cellulitis Cloxacillin 500- Cephalexin 500mg 1000mg P.O. 6th P.O Q 6 h for 7-10 days hourly for 7-10 days including normalization of temperature and WBC count & return of GI function USG guided drainage indicated in large abscesses, signs of imminent rupture, and no response to medical treatment Comment Furunculosis Diabetic foot mild(localized cellulites,no systemic symptoms) Cloxacillin 500mg P.O Q 6 h for 7-10 days Cloxacillin 500mg P.O Q 6 h for 7-10 days Cephalexin 500mg P.O Q 6 h for 7-10 days Cephalexin 500mg P.O Q 6 h for 7-10 days
11 Diabetic footmoderate to severe (limb threatening) Acute adenolymphangitis CP 20lakh units I.V. Q4h + Clindamycin 600mg I.V. Q6h x 14 days+ Gentamicin 5mg/kg I.V. Q 24h Outpatient: Cap Amoxycillin 500mg 8 th hrly x 5days Inpatient: CP 15 lakh units I.V. Q4hx 7days Cefazolin 1gm IV 8hourly + Gentamicin 5mg/Kg IV /day Cap Cloxacillin 500mg 6hrly Inj Cefotaxime 1gm 8hrlyx 5days E. RESPIRATORY TRACT INFECTIONS UPPER RESPIRATORY TRACT INFECTIONS Infection/Condition/likely organism Suggested treatment Preferred Alternative Acute tonsillo-pharyngitis Amoxicillin 500mg P.O. Q8h for 10 days Group A β hemolytic streptococci Acute sinusitis Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis Amoxicillin- Clavulanate 500/125mg p.o bd x10 days LOWER RESPIRATORY TRACT INFECTIONS Penicillin VK 500 mg P.O. Q8h for 10 days OR In Penicillin allergic patients, Azithromycin 500 mg od for 5days Azithromycin 500 mg od for 5days Comment * If S.pneumoniae prevalence >10%,start high dose amoxicillin mg/kg/day in 2 diviided doses Community acquired pneumonia (Outpatient) Azithromycin 500mg P.O. od for 5 days or Doxycycline 100mg P.O. bd for 7 days Tab Amoxyclav 1gm BD +Azithromycin 500mg od for 7 days
12 Community acquired pneumonia (Inpatient) (hospitalized but not in ICU, NOT CRITICALLY ILL) Inj Amoxyclav 1.2 gm Q8h for 5-7 days + Inj Azithromycin 500 mg od for 5-7 days Switch to oral when clinically appropriate Inj Cefotaxime 1gm Q8h or Inj Ceftriaxone 2gm od + inj Azithromycin 500mg od for 5-7 days *Add Vancomycin or clindamycin for suspected CA- MRSA Lung abscess or aspiration pneumonia Inj Ceftriaxone 2gm BD plus inj Clindamycin 600mg Q8h switch to oral when clinically stable treat for 4-6 weeks Inj Ceftriaxone 2gm BD PLUS inj Metronidazole 500mg Q8h Or Inj Crystalline Penicillin 2 million units Q4h G. GENITOURINARY INFECTIONS Infection/Condition/likely Suggested treatment organism Preferred Acute Nitrofurantoin 100mg uncomplicated P.O. BD for 7 days cystitis in Non pregnant women Acute pyelonephritis (no underlying GU disease) Complicated UTI (underlying GU disease) Catheter Amikacin 15mg/kg I.V Q24H for 7 days (mild illness) or 14 days(severe illness) Cefoperazone sulbactam Or Piperacillintazobactam x days Treat only when Alternative Ciprofloxacin 500mg BD P.O for 5 days Comment
13 associated UTI patient has systemic symptoms H. TROPICAL INFECTIONS Infection/Conditi on/likely organism Scrub Typhus(Adults) Uncomplicated Scrub Typhus(Adults) complicated Leptospirosis Malaria P.vivax Suggested treatment Preferred Doxycycline 200 mg/day in two divided doses for individuals above 45 kg for duration of 7 days Intravenous doxycycline (wherever available) 100mg twice daily in 100 ml normal saline to be administered as infusion over half an hour initially followed by oral therapy to complete 7-15 days of therapy. Tab.Doxycycline 100mg x7days Chloroquine 25mg/Kg *x 3days + Primaquine 0.25mg/kg x 14 days Artesunate 4 mg/kg body weight daily for 3 Alternative Azithromycin 500 mg in a single oral dose for 5 days Intravenous Azithromycin in the dose of 500mg IV in 250 ml normal saline over 1 hour once daily for 1-2 days followed by oral therapy to complete 5 days of therapy Pregnancy/lactation: Capsule Ampicillin 500mg 6hrly Comment In children Doxycycline 4.5mg/Kg body weight/day in 2 divided doses Or Single dose Azithromycin 10mg/Kg body wt for 5 days Children(<8yrs) : Amoxycillin/A mpicillin 30-50mg/Kg/day in divided doses for 7 days Chloroquine: 25 mg/kg body weight divided over three days i.e. 10 mg/kg on day 1, 10 mg/kg on day 2 and
14 P.falciparum days Sulfadoxine (25 mg/kg body weight) Pyrimethamine (1.25 mg/kg body weight) on first day+primaquine 0.25mg/kg single dose on second day 5 mg/kg on day 3. All mixed infections should be treated with full course of ACT and Primaquine 0.25 mg per kg body weight daily for 14 days Melioidosis Burkholderia Pseudomallei Initial parentral( Intensive phase): Ceftazidime 1gm iv every 6 hrs for 10 days /Minus Trimethoprim/Sulpham ethoxazole 8/40mg/kg/24h IV for 2-3 weeks Inj Meropenem 1gm# iv 8hrly for 10days # If malaria is acquired in North-eastern states ; treatment strategy for P.f and mixed infections will include Artemether and Lumifantrine # Refer NVBDCP 2013 Diagnosis and Treatment Guidelines #2gm for CNS Infections Maintenance Therapy: Trimethoprim/Sulpham ethoxazole 10/50mg/kg/24h PO β-lactam/β-lactamase inhibitors, e.g. Amoxycillin/Clavulana te 1250mg
15 PLUS Doxycycline 100mg PO q12h Duration minimum 20 weeks (2 tablets of 625mg) PO q8h OR Trimethoprim/Sulpham ethoxazole 8/40mg/kg/24h Duration minimum 20 weeks
Suggested treatment. Inj Crystalline Penicillin 50,000U/Kg i.v. 4-6hrly (if child cannot swallow) 40mg/Kg/dose BID x 10days
GUIDELINES FOR TREATMENT OF INFECTIONS IN CHILDREN A. RESPIRATORY TRACT INFECTIONS UPPER RESPIRATORY TRACT INFECTIONS Infection/Condition/likely organism Suggested treatment Preferred Alternative Acute
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationGuidelines for Antimicrobial treatment for treatment of confirmed infections adults
Guidelines for Antimicrobial treatment for treatment of confirmed infections adults This guideline gives recommendations for treatment of confirmed infections in adults for children please see the Paediatric
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationHandbook of. Antimicrobial Use at JIPMER. Edited by. Dr Subhash C.Parija Dr Sujatha Sistla Dr Jharna Mandal
Handbook of Antimicrobial Use at JIPMER Edited by Dr Subhash C.Parija Dr Sujatha Sistla Dr Jharna Mandal Department of Microbiology JIPMER - Pondicherry 2013 Contents Page GI and intra Abdominal Infections...5-7
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationCentral Nervous System Infections
Central Nervous System Infections Meningitis Treatment Bacterial meningitis is a MEDICAL EMERGENCY. ANTIBIOTICS SHOULD BE STARTED AS SOON AS THE POSSIBILITY OF BACTERIAL MENINGITIS BECOMES EVIDENT, IDEALLY
More informationnumber Done by Corrected by Doctor Dr.Malik
number 27 Done by Fatimah Farhan Corrected by Basil Al-Bakri Doctor Dr.Malik Note: anything in red is just extra info and you will not be asked about it in the exam. In this sheet we will continue talking
More informationInfection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be
Gastrointestinal Infections Infection Comments First Line Agents Penicillin Allergy History of multiresistant Campylobacter Antibiotics not recommended. Erythromycin 250mg PO 6 Alternative to first N/A
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationOBSTETRICS & GYNAECOLOGY. Penicillin G 5 million units IV ; followed by 2.5 million units 4hourly upto delivery
OBSTETRICS & GYNAECOLOGY A.OBSTETRICS Infection/Condition/likely organism Intrapartum Group B Streptococcal (GBS) infection; positive mothers Suggested treatment Preferred Penicillin G 5 million units
More informationß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems
β-lactams ß-lactams Sub-families Penicillins Cephalosporins Monobactams Carbapenems ß-lactams Mode of action PBPs = Trans/Carboxy/Endo- peptidases PBP binding (Penicillin-Binding Proteins) activation of
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationManagement of Native Valve
Management of Native Valve Infective Endocarditis 2005 AHA 2015 Baddour LM, et al. Circulation. 2015;132(15):1435-86 2009 ESC 2015 Habib G, et al. Eur Heart J. 2015;36(44):3075-128 ESC 2015: Endocarditis
More informationWomen s Antimicrobial Guidelines Summary
Women s Antimicrobial Guidelines Summary 1. Introduction and Who Guideline applies to This guideline has been developed to deliver safe and appropriate empirical use of antibiotics for patients at University
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationyour hospitals, your health, our priority PARC (Policy Approval and Ratification Committee) STANDARD OPERATING PROCEDURE:
STANDARD OPERATING PROCEDURE: TRUST ANTIBIOTIC TREATMENT SOP SOP NO: TW10/136 SOP 1 VERSION NO: VERSION 6.1 (JANUARY 2013) APPROVING COMMITTEE: INFECTION PREVENTION AND CONTROL COMMITTEE DATE THIS VERSION
More informationINFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: DEC 2015
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationPrescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children
Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children Prescribing Antimicrobials for Common Illnesses When treating common illnesses such as ear infections and strep throat,
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationAntibiotic Usage Guidelines in Hospital
SUPPLEMENT TO JAPI december VOL. 58 51 Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The
More informationINFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: APRIL
More information** the doctor start the lecture with revising some information from the last one:
Page 1 of 7 ** the doctor start the lecture with revising some information from the last one: #penicillin G has a good susceptibility against gram(+ve), Neisseria (-ve) #mostly active against strep. (don
More informationANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE
ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE Version 1.0 Date ratified June 2009 Review date June 2011 Ratified by Authors Consultation Nottingham Antibiotic Guidelines Committee
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Community Acquired 1) Is it pneumonia? ie new symptoms and signs of a lower respiratory
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationDRAFT DRAFT. Paediatric Antibiotic Prescribing Guideline. May
Paediatric Antibiotic Prescribing Guideline www.oxfdahsn.g/children Magdalen Centre Nth, 1 Robert Robinson Avenue, Oxfd Science Park, OX4 4GA, United Kingdom t: +44(0) 1865 784944 e: info@oxfdahsn.g Follow
More informationPIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
More informationClinical Practice Standard
Clinical Practice Standard 1-20-6-1-010 TITLE: INTRAVENOUS TO ORAL CONVERSION FOR ANTIMICROBIALS A printed copy of this document may not reflect the current, electronic version on OurNH. APPLICABILITY:
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More informationnumber Done by Corrected by Doctor
number 28 Done by Dina Yaseen Corrected by حسام أبو عوض Doctor مالك الزحلف Cephalosporins -Cephalosporins are β-lactam antibiotics isolated from a strain of Streptomyces. -They are bactericidal and work
More informationDrug Class Prior Authorization Criteria Intravenous Antibiotics
Drug Class Prior Authorization Criteria Intravenous Antibiotics Line of Business: Medicaid P&T Approval Date: August 15, 2018 Effective Date: October 1, 2018 This drug class prior authorization criteria
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationCommunity Acquired Pneumonia: An Update on Guidelines
Community Acquired Pneumonia: An Update on Guidelines Claudia Summa, BScPhm Pharmacy Resident September 12, 2006 Objectives To give a brief description of the pathophysiology of community acquired pneumonia
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationNational Antimicrobial Prescribing Survey
Indication documented Surgical prophylaxis >24 hrs Allergy mismatch Microbiology mismatch Incorrect route Incorrect dose/frequency Incorrect duration Therapeutic Guidelines Local guidelines * Non-compliant
More informationPharmacology Week 6 ANTIMICROBIAL AGENTS
Pharmacology Week 6 ANTIMICROBIAL AGENTS Mechanisms of antimicrobial action Mechanisms of antimicrobial action Bacteriostatic - Slow or stop bacterial growth, needs an immune system to finish off the microbe
More informationCase 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance
Case 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance 22nd Congress of the EAHP "Hospital pharmacists catalysts for change", 22-24 March 2017, Cannes Disclosure
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationOPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials
Clinical Monitoring of Outpatient Parenteral Antimicrobial Therapy (OPAT) and Selected Oral Antimicrobial Agents Adult Inpatient/Ambulatory Clinical Practice Guideline Appendix A. Coordinating an OPAT
More informationThese recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.
Antibiotic regimens for suspected hospital-acquired infection (HAI) outside the Paediatric Intensive Care Unit at Red Cross War Memorial Children s Hospital (RCWMCH) Lead author: Brian Eley Contributing
More informationVCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS
VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS CARDIAC Staphylococcus aureus, S. epidermidis, except for For patients with known MRSA colonization, recommend decolonization with Antimicrobial Photodynamic
More informationHead to Toe: Common infections in Hospital settings. Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases
Head to Toe: Common infections in Hospital settings Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases Objectives To identify at least one common infection in
More informationDiscussion Points. Decisions in Selecting Antibiotics
Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationAntibiotic Updates: Part I
Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationGASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT
GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT DRAFT AS CURRENTLY OUT FOR CONSULTATION BUT CAN BE UTILISED IN PRESENT FORMAT Name & Title Of Author: Date Revised: Approved by Committee/Group:
More informationSepticaemia Definitions 1
Septicaemia Definitions 1 Term Definition Bacteraemia Systemic Inflammatory response (SIRS) Sepsis Bacteria that can be cultured from the blood stream The systemic response to a wide range of stresses.
More informationPneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC
Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC APPROVED BY: Policy and Guidelines Committee TRUST REFERENCE: B9/2009 AWP Ref: AWP61 Date (approved): July 2008 REVIEW
More informationInfectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles
Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationAntibiotics 1. Lecture 8
Antibiotics 1 Lecture 8 Overview of antibiotics What am I treating? Viral, bacterial, fungal, mycobacterial, etc. Who am I treating? Host factors: age, genetic factors, co-morbidities (renal and liver
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationTreatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani
Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani 30-1-2018 1 Objectives of the lecture At the end of lecture, the students should be able to understand the following:
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Pneumonia Community Acquired Pneumonia 1) Is it pneumonia? ie new symptoms and signs of
More informationTOH GUIDELINES FOR EMPIRIC ANTIBIOTIC THERAPY
TOH GUIDELINES FOR EMPIRIC ANTIBIOTIC THERAPY Developed by the Antimicrobial Subcommittee of the Pharmacy & Therapeutics Committee CONTENTS BONE AND JOINT INFECTIONS 2 CENTRAL NERVOUS SYSTEM INFECTIONS
More informationCopyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at
Malignant Otitis Externa Inflammation and damage at the base of the skull due to an untreated outer ear P. aeruginosa most common organism Yellow-green drainage from the ear Odor Fever Deep inner ear pain
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationTelephone Max dose amoxicillin pediatrics P.O. Box 189 Navan, ON, K4B 1J4 Canada. Sitemap
Telephone 613-835-9490 Max dose amoxicillin pediatrics P.O. Box 189 Navan, ON, K4B 1J4 Canada Sitemap 25 mg/kg/ dose ( Max : 500 mg/ dose ) PO twice daily for 10 days is recommended by the Infectious Diseases
More informationAntibiotics Guidelines: Gastrointestinal Infections
Antibiotics Guidelines: Gastrointestinal Infections Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More informationChoosing the Best Antibiotic in Problem Outpatient Infectious Disease Cases
Choosing the Best Antibiotic in Problem Outpatient Infectious Disease Cases Dr. Earl Rubin Associate Professor Department of Pediatrics Division of Infectious Diseases Montreal Children s Hospital Disclosures
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationProvincial Drugs & Therapeutics Committee Memorandum Version 2
Provincial Drugs & Therapeutics Committee Memorandum Version 2 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada
More informationHealth PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults
Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults COMMUNITY-ACQUIRED PNEUMONIA HEALTHCARE-ASSOCIATED PNEUMONIA INTRA-ABDOMINAL INFECTION
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationVolume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000.
Volume 8; Number 22 LINCOLNSHIRE GUIDELINES FOR THE TREATMENT OF COMMONLYY OCCURRING INFECTIONS IN PRIMARY CARE: WINTER 2014/15 In this issue of the PACE Bulletin we present an update of our Guidelines
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationUpdated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007
Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007 1 Ongoing data from CDC 's Gonococcal Isolate Surveillance Project (GISP), including
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationIntro Who should read this document 2 Key practice points 2 Background 2
Antibiotic Guidelines: Obstetric Anti-Infective Prescribing Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Kelly Alexander / Frances Garraghan
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationRational use of antibiotics
Rational use of antibiotics Uga Dumpis MD, PhD,, DTM Stradins University Hospital Riga, Latvia ugadumpis@stradini.lv BALTICCARE CONFERENCE, PSKOV, 16-18.03, 18.03, 2006 Why to use antibiotics? Prophylaxis
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationEAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia
EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia Background The Expert Advisory Group on Antimicrobial Resistance of the NH&MRC provides advice to Australian governments and
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #116 (NQF 0058): Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More information